Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma

Abstract

This study suggested a promising seven prognostic immune-related lncRNAs risk scoring system and may provide new information for immunological treatment in LUAD.